Coherus Biosciences (CHRS) PT Lowered to $33 at Citi

June 13, 2017 6:27 AM

Citi lowered its price target on Coherus Biosciences (NASDAQ: CHRS) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found